Oramed Pharmaceuticals Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $-0.09 | not reported | not reported | |
| Q1 FY26 | not reported | $-0.16 | not reported | not reported | |
| Q4 FY25 | $0.00 | $-0.06 | not reported | Miss |
Back to ORMP overview · ORMP holders · ORMP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.